Skip to main content

Expression and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) specific receptor (PAC1R) after traumatic brain injury in mice

  • Conference paper
Transmitters and Modulators in Health and Disease

Summary

PACAP is a pleiotropic peptide and is well known to suppress neuronal cell death after ischemic injury through PACAP specific receptor (PAC1R). However, the pathological role of PAC1R is not elicited well on traumatic injured brain. Therefore, the purpose of this study is to investigate the expression and localization of PAC1R after traumatic brain injury (TBI) with immunohistochemistry. The PAC1R-immunoreactions (ir) were detected in peri-contusional area 3h after TBI and gradually increased up to 7d. Double immunohistochemical studies were revealed that the PAC1R-ir were co-localized with a microglial marker, CD11b. At 7d after TBI, the PAC1R-ir were merged with CD11b and with GFAP, an astroglial marker. These results suggested that PAC1R expresses in microglia and astrocyte with different time points after TBI, and PACAP and its receptor might play an important role for brain injury as well as ischemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Arimuraar A (1998) Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48:301–331

    Article  Google Scholar 

  • Dohi K, Mizushima H, Nakajo S, Ohtaki H, Matsunaga S, Aruga T, Shioda S (2002) Pituitary adenylate cyclase-activating polypeptide (PACAP) prevents hippocampal neurons from apoptosis by inhibiting JNK/SAPK and p38 signal transduction pathways. Regul Pept 109:83–88

    Article  PubMed  CAS  Google Scholar 

  • Ohtaki H, Nakamachi T, Dohi K, Shioda S. (2008) Role of PACAP in Ischemic Neural Death. J Mol Neurosci 36:16–25

    Article  PubMed  CAS  Google Scholar 

  • Suzuki R, Arata S, Nakajo S, Ikenaka K, Kikuyama S, Shioda S (2003) Expression of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC1-R) in reactive astrocytes. Brain Res Mol Brain Res 115:10–20

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer

About this paper

Cite this paper

Morikawa, K. et al. (2009). Expression and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) specific receptor (PAC1R) after traumatic brain injury in mice. In: Shioda, S., Homma, I., Kato, N. (eds) Transmitters and Modulators in Health and Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-99039-0_19

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-99039-0_19

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-99038-3

  • Online ISBN: 978-4-431-99039-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics